Patents by Inventor Rupert Austin

Rupert Austin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyridopyrimidine Derivatives and Their Use as PDE4 Inhibitors
    Publication number: 20090233907
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE 4 mediated disease state.
    Type: Application
    Filed: March 20, 2007
    Publication date: September 17, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Rupert Austin, Roger Victor Bonnert, Simon Fraser Hunt, Grigorios Nikitidis, Hitesh Jayantilal Sanganee, Peter Olof Sjo, Dan Warner
  • Pteridinone Derivatives as Modulators of Chemokine Receptor Activity
    Publication number: 20070142352
    Abstract: The invention provides certain pteridinone compounds of formula (I), processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: February 8, 2007
    Publication date: June 21, 2007
    Applicant: ASTRAZENECA AB
    Inventors: Roger Bonnert, Peter Cage, Simon Hunt, Iain Alastair Walters, Rupert Austin
  • Pteridinone derivatives as modulators of chemokine receptor activity
    Publication number: 20050010047
    Abstract: The invention provides certain pteridinone compounds of formula (I), processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: August 9, 2002
    Publication date: January 13, 2005
    Inventors: Roger Bonnert, Peter Cage, Simon Hunt, Iain Alastair Walters, Rupert Austin
  • Compounds
    Patent number: 6806273
    Abstract: The invention provides certain thiazolopyrimidine compounds, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: October 21, 2001
    Date of Patent: October 19, 2004
    Assignee: AstraZeneca AB
    Inventors: Rupert Austin, Andrew Baxter, Roger Bonnert, Fraser Hunt, Elizabeth Kinchin, Paul Willis